Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-554,100
Closed -$9.53M 6185
2022
Q4
$9.53M Buy
+554,100
New +$9.83M ﹤0.01% 2638

Other funds holding RXO

Goldman Sachs's RXO Position: Q1 2026 in Review

Goldman Sachs reduced its RXO (RXO) stake by 18% in Q1 2026, selling an estimated $3.49M and leaving 1,108,873 shares worth $16.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2642.

Goldman Sachs first reported a position in RXO in Q4 2022 and has held it in 14 quarters since. The position peaked at $29.9M in Q3 2024. 275 funds tracked by Wall St. Rank hold RXO as of Q1 2026.

  • Goldman Sachs held 1,108,873 shares of RXO worth $16.2M as of Q1 2026.
  • Goldman Sachs sold 237,581 RXO shares in Q1 2026, an estimated $3.49M.
  • RXO made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2642 holding.
  • Goldman Sachs first reported a position in RXO in Q4 2022 and has held it in 14 quarters since.
  • Goldman Sachs's RXO position peaked at $29.9M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held RXO as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.